HHLR ADVISORS, LTD.
13F Holdings and Portfolio Analysis
Zhang Lei 2021 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
HHLR ADVISORS, LTD. Overview
HHLR ADVISORS, LTD. held 85 stocks in 2021 Q3, with total market value around $7.65B.
HHLR ADVISORS, LTD.'s top five holdings in 2021 Q3: BeOne Medicines AG(ONC) 25.98%, Legend Biotech Corporation(LEGN) 7.31%, NOVABRIDGE BIOSCIENCES(NBP) 6.81%, On Holding AG(ONON) 6.29%, JD.com, Inc.(JD) 4.50%.
- Portfolio Value
- $7.65B
- Current Holdings
- 85 stocks
- New / Increased
- 21 / 5
- Reduced / Exited
- 15 / 25
Current Holdings
| 1 | BeOne Medicines AGONC | 1.99 | 25.98% | 5.47 - | $363.00 | $316.42 -12.83% | $136.90 | 0.00 | 3.00 | +$0.98B+131.14% | Held |
| 2 | Legend Biotech CorporationLEGN | 0.56 | 7.31% | 11.05 +1600.76% | $50.56 | $31.96 -36.79% | $50.09 | +10.40 | 1.50 | -$0.20B-36.19% | Increased |
| 3 | NOVABRIDGE BIOSCIENCESNBP | 0.52 | 6.81% | 7.18 +8.57% | $72.49 | - | $50.06 | +0.57 | 1.25 | +$0.16B+44.79% | Increased |
| 4 | On Holding AGONON | 0.48 | 6.29% | 15.97 | $30.13 | $41.82 +38.80% | $30.13 | +15.97 | 0.25 | +$0.19B+38.80% | New |
| 5 | JD.com, Inc.JD | 0.34 | 4.50% | 4.77 +29.43% | $72.24 | $33.07 -54.22% | $59.29 | +1.08 | 3.00 | -$0.13B-44.22% | Increased |
| 6 | Salesforce, Inc.CRM | 0.34 | 4.45% | 1.25 +10.36% | $271.22 | $210.90 -22.24% | $194.01 | +0.12 | 1.75 | +$0.02B+8.70% | Increased |
| 7 | iQIYI, Inc.IQ | 0.31 | 4.06% | 38.65 - | $8.03 | $2.03 -74.72% | $18.04 | 0.00 | 3.00 | -$0.62B-88.75% | Held |
| 8 | PDD HOLDINGS INC COMMON STOCKPDD | 0.25 | 3.33% | 2.81 -59.32% | $90.67 | $88.14 -2.78% | $34.21 | -4.09 | 3.00 | +$0.15B+157.66% | Reduced |
| 9 | BridgeBio Pharma, Inc.BBIO | 0.25 | 3.29% | 5.36 - | $46.87 | $54.92 +17.17% | $20.26 | 0.00 | 2.50 | +$0.19B+171.13% | Held |
| 10 | DoorDash, Inc.DASH | 0.25 | 3.22% | 1.20 - | $205.98 | $154.61 -24.94% | $143.41 | 0.00 | 1.00 | +$0.01B+7.81% | Held |
| 11 | Cytek Biosciences, Inc.CTKB | 0.19 | 2.45% | 8.76 | $21.41 | $3.95 -81.55% | $21.41 | +8.76 | 0.25 | -$0.15B-81.55% | New |
| 12 | Beam Therapeutics Inc.BEAM | 0.13 | 1.65% | 1.45 -21.54% | $87.01 | $25.98 -70.14% | $18.00 | -0.40 | 1.75 | +$0.01B+44.33% | Reduced |
| 13 | Mondelez International, Inc.MDLZ | 0.11 | 1.42% | 1.86 - | $58.18 | $62.41 +7.27% | $40.03 | 0.00 | 3.00 | +$0.04B+55.91% | Held |
| 14 | Alibaba Group Holding LimitedBABA | 0.11 | 1.38% | 0.71 - | $148.05 | $125.39 -15.31% | $226.77 | 0.00 | 0.75 | -$0.07B-44.71% | Held |
| 15 | Sea LimitedSE | 0.11 | 1.38% | 0.33 | $318.73 | $90.53 -71.60% | $318.73 | +0.33 | 0.25 | -$0.08B-71.60% | New |
| 16 | Erasca, Inc.ERAS | 0.10 | 1.31% | 4.72 | $21.22 | $2.42 -88.60% | $21.22 | +4.72 | 0.25 | -$0.09B-88.60% | New |
| 17 | Vipshop Holdings LimitedVIPS | 0.10 | 1.31% | 8.96 - | $11.14 | $14.22 +27.65% | $1.49 | 0.00 | 0.75 | +$0.11B+852.44% | Held |
| 18 | Gossamer Bio, Inc.GOSS | 0.09 | 1.22% | 7.42 - | $12.57 | $2.19 -82.58% | $16.64 | 0.00 | 2.75 | -$0.11B-86.84% | Held |
| 19 | KE Holdings Inc.BEKE | 0.09 | 1.20% | 5.01 - | $18.26 | $18.29 +0.16% | $61.29 | 0.00 | 1.25 | -$0.22B-70.16% | Held |
| 20 | Playtika Holding Corp.PLTK | 0.09 | 1.19% | 3.28 - | $27.63 | $3.52 -87.26% | $27.21 | 0.00 | 0.75 | -$0.08B-87.06% | Held |
| 21 | Illumina, Inc.ILMN | 0.07 | 0.89% | 0.17 | $405.61 | $95.46 -76.47% | $405.61 | +0.17 | 0.25 | -$0.05B-76.47% | New |
| 22 | Coupang, Inc.CPNG | 0.06 | 0.79% | 2.18 | $27.85 | $16.68 -40.11% | $27.85 | +2.18 | 0.25 | -$0.02B-40.11% | New |
| 23 | TANGO THERAPEUTICS INCTNGX | 0.06 | 0.74% | 4.37 | $12.93 | - | $12.93 | +4.37 | 0.25 | $0.00B0.00% | New |
| 24 | Affiliated Managers Group, Inc.AMG | 0.05 | 0.66% | 0.34 - | $151.09 | $235.60 +55.93% | $28.12 | 0.00 | 2.00 | +$0.07B+737.75% | Held |
| 25 | Uber Technologies, Inc.UBER | 0.05 | 0.65% | 1.11 -79.45% | $44.80 | $73.03 +63.01% | $29.85 | -4.31 | 2.25 | +$0.05B+144.64% | Reduced |
Showing 1-25 of 85
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2021 Q3.
| 1 | ENSTAR GROUP LIMITEDESGR | 1.75 | 2.50 | $184.97 | $238.92 | +$0.09B+29.17% |
| 2 | ZOOM VIDEO COMMUNICATION INCUSIP 98980L101 | 1.03 | 1.75 | $180.18 | $261.50 | +$0.08B+45.13% |
| 3 | Apellis Pharmaceuticals, Inc.APLS | 2.93 | 2.75 | $28.69 | $63.20 | +$0.10B+120.30% |
| 4 | FibroGen, Inc.FGEN | 3.96 | 2.75 | $43.86 | $26.63 | -$0.07B-39.28% |
| 5 | KODIAK SCIENCES INCKOD | 0.81 | 0.75 | $146.91 | $93.00 | -$0.04B-36.70% |
| 6 | BLUEPRINT MEDICINES CORPBPMC | 0.64 | 2.75 | $55.41 | $87.96 | +$0.02B+58.74% |
| 7 | Otis Worldwide CorporationOTIS | 0.61 | 1.25 | $56.86 | $82.28 | +$0.02B+44.70% |
| 8 | DIDI GLOBAL INCDIDIY | 3.02 | 0.25 | $14.14 | $7.79 | -$0.02B-44.91% |
| 9 | GDS Holdings LimitedGDS | 0.39 | 1.25 | $81.78 | $56.61 | -$0.01B-30.78% |
| 10 | Apple Inc.AAPL | 0.20 | 0.75 | $132.69 | $141.50 | +$0.00B+6.64% |
| 11 | AXSOME THERAPEUTICS INCAXSM | 0.36 | 0.75 | $81.47 | $67.46 | -$0.01B-17.19% |
| 12 | Olema Pharmaceuticals, Inc.OLMA | 0.62 | 0.75 | $48.08 | $27.98 | -$0.01B-41.80% |
| 13 | Kura Oncology, Inc.KURA | 0.65 | 0.75 | $32.66 | $20.85 | -$0.01B-36.16% |
| 14 | IGM BIOSCIENCES INCTDG | 0.15 | 2.00 | $17.75 | $83.20 | +$0.01B+368.71% |
| 15 | Avidity Biosciences, Inc.RNA | 0.42 | 1.25 | $28.26 | $24.71 | -$0.00B-12.56% |
| 16 | Nkarta, Inc.NKTX | 0.28 | 1.00 | $30.06 | $31.69 | +$0.00B+5.43% |
| 17 | Cogent Biosciences, Inc.COGT | 1.00 | 0.75 | $11.23 | $8.11 | -$0.00B-27.78% |
| 18 | LEAP THERAPEUTICS INCLF | 3.58 | 1.25 | $2.09 | $1.64 | -$0.00B-21.41% |
| 19 | MONTES ARCHIMEDES ACQUISITIOCUSIP 612657205 | 0.50 | 0.75 | $10.50 | $10.68 | +$0.00B+1.71% |
| 20 | NetEase, Inc.NTES | 0.04 | 0.50 | $103.26 | $85.40 | -$0.00B-17.30% |
| 21 | Cytokinetics, IncorporatedCYTK | 0.23 | 0.25 | $19.79 | $19.79 | $0.00B0.00% |
| 22 | CHINA JO-JO DRUGSTORES INCCJJD | 4.84 | 2.00 | $1.21 | $0.94 | -$0.00B-22.20% |
| 23 | HOOKIPA Pharma Inc.HOOK | 0.27 | 2.25 | $7.27 | $9.16 | +$0.00B+26.04% |
| 24 | DRAGONEER GROWTH OPPORTUNITY CODGNS | 0.20 | 1.00 | $12.25 | $10.39 | -$0.00B-15.18% |
| 25 | New Oriental Education & Technology Group Inc.EDU | 0.08 | 0.50 | $14.00 | $2.05 | -$0.00B-85.36% |
Showing 1-25 of 25
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.